akhatri

The Department of Health and Social Care (DHSC) has today (29/08/2025) confirmed the following list of price concessions for August 2025: Drug Pack size Price concession Nefopam 30mg tablets 90 £4.09 Olanzapine 10mg tablets 28 £4.99 Olanzapine 2.5mg tablets 28 £3.51 Olanzapine 20mg tablets 28 £4.99 Olanzapine 7.5mg tablets 28 £1.25 Propranolol 80mg modified-release capsules 28 £5.94 Repaglinide [...]

The post August 2025 Price Concessions 5th Update appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 September 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Simeticone 42mg/5ml oral drops Dentinox® Infant colic drops (Dendron Brands Ltd) 100 ml [...]

The post 9 products re-classified as special containers from September 2025 appeared first on Community Pharmacy England.

Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 2 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 September 2025. This takes the total number [...]

The post Ciclosporin eye drops and Winlevi® cream added to the Discount Not Deducted (DND) list appeared first on Community Pharmacy England.

Following a decision taken by Eli Lilly to increase its UK list prices for Mounjaro® (Tirzepatide) KwikPen® from 1 September 2025, the Department of Health and Social Care (DHSC) has re-determined the NHS reimbursement prices for all strengths of Mounjaro® dispensed from September to reflect the new, higher list prices. To avoid pharmacy owners dispensing [...]

The post Mounjaro® reimbursement prices redetermined for September 2025 appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Notification: Various Products (Ipca Laboratories UK Limited) Date issued: 26 August 2025 Ipca Laboratories UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information. DMRC reference number: DMRC-35766519 Marketing Authorisation Holder: Ipca Laboratories UK [...]

The post MHRA Class 4 Medicines Notification Various Products (Ipca Laboratories UK Limited) appeared first on Community Pharmacy England.